Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis

Objective: To evaluate the cost utility of epidermal growth factor receptor (EGFR) testing plus first-line gefitinib treatment in patients with activating EGFR mutations in Thailand. Methods: The study used a decision tree model considering the provider's perspective. Direct medical costs were...

Full description

Saved in:
Bibliographic Details
Main Authors: Unchalee Permsuwan, Narawadee Niamhun, Narumon Tanatip, Sumitra Thongprasert
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897471037&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/53467
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University